Eye on emu for BioProspect

By Kate McDonald
Monday, 11 May, 2009

Brisbane’s BioProspect is hoping to enter the human natural health market by purchasing Melbourne dietary supplement company Re-Gen.

BioProspect is close to commercialisation with its lead product, a natural solution for termites called Termilone, and is also developing a range of plant extracts for animal health and nutrition called Bioeffectives.

The company said in a statement that Re-Gen’s product range was a natural fit with BioProspect’s other products.

Re-Gen has developed a range of products, including purified emu oil, as dietary supplements and as a therapy for skin, muscle and joint conditions. The company already has approval to market seven products in China, and will be concentrating on this market as well as Australia and overseas.

BioProspect is currently doing due diligence and will make a decision within 90 days.

Related News

Defective sperm doubles pre-eclampsia risk in IVF patients

A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...

Free meningococcal B vaccines coming to the NT

The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...

Mouth bacteria linked to increased head and neck cancer risk

More than a dozen bacterial species that live in people's mouths have been linked to a...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd